Cargando…
Idiopathic CD4 Lymphocytopenia: Current Insights
Idiopathic CD4 lymphocytopenia is a condition characterized by low CD4 counts. It is rare and most of the information about this illness comes from case reports. Presentation is usually in the 4th decade of life with opportunistic infections, autoimmune disease or neoplasia. The pathophysiology of t...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239889/ https://www.ncbi.nlm.nih.gov/pubmed/32548074 http://dx.doi.org/10.2147/ITT.S214139 |
_version_ | 1783536771759341568 |
---|---|
author | Vijayakumar, Saravanakumari Viswanathan, Stalin Aghoram, Rajeswari |
author_facet | Vijayakumar, Saravanakumari Viswanathan, Stalin Aghoram, Rajeswari |
author_sort | Vijayakumar, Saravanakumari |
collection | PubMed |
description | Idiopathic CD4 lymphocytopenia is a condition characterized by low CD4 counts. It is rare and most of the information about this illness comes from case reports. Presentation is usually in the 4th decade of life with opportunistic infections, autoimmune disease or neoplasia. The pathophysiology of this condition is not well understood. Management revolves around treatment of the presenting condition and close follow-up of these patients. This review presents a narrative summary of the current literature on idiopathic CD4 lymphocytopenia. |
format | Online Article Text |
id | pubmed-7239889 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-72398892020-06-15 Idiopathic CD4 Lymphocytopenia: Current Insights Vijayakumar, Saravanakumari Viswanathan, Stalin Aghoram, Rajeswari Immunotargets Ther Review Idiopathic CD4 lymphocytopenia is a condition characterized by low CD4 counts. It is rare and most of the information about this illness comes from case reports. Presentation is usually in the 4th decade of life with opportunistic infections, autoimmune disease or neoplasia. The pathophysiology of this condition is not well understood. Management revolves around treatment of the presenting condition and close follow-up of these patients. This review presents a narrative summary of the current literature on idiopathic CD4 lymphocytopenia. Dove 2020-05-14 /pmc/articles/PMC7239889/ /pubmed/32548074 http://dx.doi.org/10.2147/ITT.S214139 Text en © 2020 Vijayakumar et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Vijayakumar, Saravanakumari Viswanathan, Stalin Aghoram, Rajeswari Idiopathic CD4 Lymphocytopenia: Current Insights |
title | Idiopathic CD4 Lymphocytopenia: Current Insights |
title_full | Idiopathic CD4 Lymphocytopenia: Current Insights |
title_fullStr | Idiopathic CD4 Lymphocytopenia: Current Insights |
title_full_unstemmed | Idiopathic CD4 Lymphocytopenia: Current Insights |
title_short | Idiopathic CD4 Lymphocytopenia: Current Insights |
title_sort | idiopathic cd4 lymphocytopenia: current insights |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239889/ https://www.ncbi.nlm.nih.gov/pubmed/32548074 http://dx.doi.org/10.2147/ITT.S214139 |
work_keys_str_mv | AT vijayakumarsaravanakumari idiopathiccd4lymphocytopeniacurrentinsights AT viswanathanstalin idiopathiccd4lymphocytopeniacurrentinsights AT aghoramrajeswari idiopathiccd4lymphocytopeniacurrentinsights |